After 12 days, the tumor volume in HCT116-SMYD3-KO-xenografted mice was significantly lower compared to HCT116-xenografted mice (Fig. 3E), in line with previous studies showing that SMYD3 deficiency inhibits tumor development [24, 25]. The gene discussed is SMYD3; the disease is neoplasm.